EverSource Wealth Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5K Sell
129
-513
-80% -$7.32K ﹤0.01% 3831
2026
Q1
$10.8K Sell
642
-251
-28% -$4.49K ﹤0.01% 2873
2025
Q4
$14.3K Buy
893
+762
+582% +$11.3K ﹤0.01% 2602
2025
Q3
$1.62K Sell
131
-800
-86% -$9.38K ﹤0.01% 3579
2025
Q2
$10.7K Buy
931
+798
+600% +$9.46K ﹤0.01% 2764
2025
Q1
$1.99K Sell
133
-31
-19% -$519 ﹤0.01% 2932
2024
Q4
$2.84K Buy
164
+31
+23% +$598 ﹤0.01% 2577
2024
Q3
$2.46K Hold
133
﹤0.01% 2474
2024
Q2
$3.26K Hold
133
﹤0.01% 2374
2024
Q1
$2.1K Buy
133
+31
+30% +$488 ﹤0.01% 2369
2023
Q4
$1.8K Sell
102
-19
-16% -$383 ﹤0.01% 2199
2023
Q3
$2.9K Buy
121
+19
+19% +$466 ﹤0.01% 1894
2023
Q2
$2.37K Hold
102
﹤0.01% 1981
2023
Q1
$2.25K Buy
102
+2
+2% +$47 ﹤0.01% 1904
2022
Q4
$2.03K Hold
100
﹤0.01% 1911
2022
Q3
$1K Hold
100
﹤0.01% 1790
2022
Q2
$2K Hold
100
﹤0.01% 1476
2022
Q1
$3K Hold
100
﹤0.01% 1403
2021
Q4
$2K Buy
+100
New +$2.61K ﹤0.01% 1518

Other funds holding CLB

EverSource Wealth Advisors's CLB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Core Laboratories (CLB) stake by 80% in Q2 2026, selling an estimated $7.32K and leaving 129 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3831.

EverSource Wealth Advisors first reported a position in CLB in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.3K in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • EverSource Wealth Advisors held 129 shares of Core Laboratories worth $1.5K as of Q2 2026.
  • EverSource Wealth Advisors sold 513 Core Laboratories shares in Q2 2026, an estimated $7.32K.
  • Core Laboratories made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3831 holding.
  • EverSource Wealth Advisors first reported a position in Core Laboratories in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Core Laboratories position peaked at $14.3K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.